Our Mission
We develop cutting edge technologies that transform cell-based assays into physiologically predictive tools
Lena Biosciences, Inc. was established in 2008 with a goal of improving cell culture techniques by providing a more physiologically relevant method. In 2010, our SeedEZ 3D cell culturing scaffold was conceived. In 2016, our PerfusionPal system was born, combining 3D cell culture with perfusion. This biomimetic cell culturing method enriches oxygen supply to cell culture using our Blood Substitute, the PerfusionPal inserts and SeedEZ scaffolds. This trifecta directs oxygen supply to the cells, mimicking in vivo perfusion and providing a stable method to study pharmacodynamics and cell interactions.
At Lena Biosciences, we offer innovative 3D cell culture products to make in vitro drug metabolism and drug discovery research more efficient and cost-effective. Our goal is to expand the capabilities of our current technology and answer questions that are beyond reach for researchers using standard 2D cell culture methods. Our patented products are backed by prestigious awards from the National Institute of Health, the National Science Foundation, the Georgia Research Alliance and the Marcus Foundation. Our office is located on the Georgia Institute of Technology campus.
At Lena Biosciences, we offer innovative 3D cell culture products to make in vitro drug metabolism and drug discovery research more efficient and cost-effective. Our goal is to expand the capabilities of our current technology and answer questions that are beyond reach for researchers using standard 2D cell culture methods. Our patented products are backed by prestigious awards from the National Institute of Health, the National Science Foundation, the Georgia Research Alliance and the Marcus Foundation. Our office is located on the Georgia Institute of Technology campus.
Team
Jelena VukasinovicCEO & PresidentJelena Vukasinovic is the Chief Executive Officer and President of Lena Biosciences. She is an accomplished entrepreneur who has over 20 years of experience developing new biotechnology products.
|
James T. ShoemakerChief Scientific OfficerJames Shoemaker serves as the Chief Scientific Officer for Lena Biosciences. He is a recognized biomedical engineer who brings over 10 years of experience in the development and application of 3D tissue models for applied research and pharmaceutical testing.
|
Wanrui Zhang
Research Scientist |
Selin Atlas
R&D Scientist |
Advisory Board
Ken Dixon, MD, FACSScientific Advisor
Founder and CEO at SpeciCare
Cancer surgeon |
Michelle C. LaPlaca, PhDScientific Advisor
Associate Professor of Biomedical Engineering
Georgia Institute of Technology & Emory University |
Albert P. Li, PhD, MBAScientific Advisor
President and CEO
In Vitro ADMET Laboratories |
Joseph L. Beverly, MBABusiness Advisor and Board Member
C-level Executive
Former president at the Atlanta Technology Angels |
Lena Biosciences Alumni
- Brian D'Agostino- Biomedical Engineering; Georgia Tech '20
- Katherine Richardson- Biomedical Engineering; Georgia Tech '18
- Ayan Dasgupta- Biomedical Engineering; Georgia Tech
- Gabriella Dweck- Biomedical Engineering; Georgia Tech '19
- Shaily Shah- Biomedical Engineering; Georgia Tech '19
- Krina Patel- Biomedical Engineering; Georgia Tech '19
- Vikram Varadarajan- Biomedical Engineering; Georgia Tech '19
- Andrew Pan- Biomedical Engineering; Georgia Tech '19
- Colton Duncan- Human Health; Emory University '20
- Marton Varga - Chemical Engineering; Georgia Tech '20
Join Our Team
We are always looking for highly motivated individuals to join our team.
For consideration, please email hr@lenabio.com